Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gynecology

  Free Subscription

Articles published in
Hum Pathol
    November 2026
  1. DASHTI NK, Ameline B, Alzayadneh E, Fanburg-Smith JC, et al
    Methylome profiling of uterine mesenchymal tumors identifies histologic mimics and reveals epigenetic heterogeneity among smooth muscle tumors classified as STUMP.
    Hum Pathol. 2026 Nov 16:106309. doi: 10.1016/j.humpath.2026.106309.
    >> Share

  2. HATANO Y, Taniguchi K, Toji A, Terada S, et al
    Single-section assessment of DNA mismatch repair using PMS2/MSH6 double immunohistochemistry.
    Hum Pathol. 2026;177:106215.
    >> Share

    October 2026
  3. AVELLANET CRESPO NI, Corines J, Ross JS, Nasr MR, et al
    TP53 Y220C hotspot mutation in clinically advanced ovarian carcinoma: Frequency and genomic features.
    Hum Pathol. 2026;178:106288.
    >> Share

    August 2026
  4. MILLS AM, Vidis L, Carlson DK, Crawford MP, et al
    Pathologist-Recommended Molecular Testing in Endometrial Cancer: A Single-Institution Experience Highlighting the Recognition of POLE-Mutated Carcinomas in Post-Menopausal and Advanced Stage Patients, Immunohistochemical Pitfalls, and Other Clinically
    Hum Pathol. 2026 Aug 18:106237. doi: 10.1016/j.humpath.2026.106237.
    >> Share

    June 2026
  5. HAW Y, Osunkoya AO
    Metastatic Malignant Non-Cervical Gynecological Tumors Involving the Genitourinary System: A Contemporary Clinicopathologic Analysis of 27 Patients.
    Hum Pathol. 2026 Jun 3:106193. doi: 10.1016/j.humpath.2026.106193.
    >> Share

    May 2026
  6. JAMSHED A, Zhu F, Cartwright D, Turner K, et al
    Gastrointestinal Tract Endometriosis: Clinicopathologic Features and Anatomic Distribution in an Institutional Cohort.
    Hum Pathol. 2026 May 27:106171. doi: 10.1016/j.humpath.2026.106171.
    >> Share

  7. QI Y, Yao Q, Xu Y, Yu L, et al
    Dedifferentiated/Undifferentiated Endometrial Carcinoma:SWI/SNF-deficiency and molecular heterogeneity indicating novel prognostic stratification in a single-center study of 71 cases.
    Hum Pathol. 2026 May 19:106155. doi: 10.1016/j.humpath.2026.106155.
    >> Share

    April 2026
  8. ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
    Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
    Hum Pathol. 2026;170:106052.
    >> Share

  9. D'ANGELO E, Kingsley LG, Espinosa I, Cipriani V, et al
    Mullerian Adenosarcoma of the Uterus, Ovary and Peritoneum: Whole Transcriptomic Digital Spatial Profiling (DSP) in a Cohort of 42 Tumors.
    Hum Pathol. 2026 Apr 1:106117. doi: 10.1016/j.humpath.2026.106117.
    >> Share

    March 2026
  10. WANG X, Wang W, Chen J, Yang J, et al
    Expression Characteristics of Clinically Relevant Antibody-Drug Conjugate Targets in Gestational Trophoblastic Neoplasia.
    Hum Pathol. 2026 Mar 9:106102. doi: 10.1016/j.humpath.2026.106102.
    >> Share

    February 2026
  11. CALEJERO I, Mobarki M, Musawi S, Peoc'h M, et al
    The molecular profile of ovarian struma ovarii.
    Hum Pathol. 2026;171:106069.
    >> Share

  12. ZHANG Z, Feng P, Ge Z, Liang Z, et al
    PIK3R1 acts as a prominent biomarker for tumor immune microenvironment modulation in intravenous leiomyomatosis.
    Hum Pathol. 2026;168:106002.
    >> Share

    January 2026
  13. YANG Y, Sun S, Xi Y, Xu C, et al
    Correlation analysis of TP53 missense mutations and p53 protein expression patterns in endometrial carcinoma.
    Hum Pathol. 2026;171:106056.
    >> Share

    December 2025
  14. NAM GH, Tan HM, Quddus MR, Dong J, et al
    Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma: Diagnostic Criteria, Differential Diagnosis, and Molecular Insights.
    Hum Pathol. 2025 Dec 29:106031. doi: 10.1016/j.humpath.2025.106031.
    >> Share

  15. BUZA N, Sun T, Hui P
    Endometrial Carcinomas - Challenges and Updates on Selected Topics.
    Hum Pathol. 2025 Dec 11:106016. doi: 10.1016/j.humpath.2025.106016.
    >> Share

  16. YANG F, Liu Y, Wang Y, Yang J, et al
    Ovarian GLI1 fusion tumors Mimicking Sex Cord-Stromal Tumors: Clinicopathological and Molecular Characterization of a Five-Case Series.
    Hum Pathol. 2025 Dec 9:106003. doi: 10.1016/j.humpath.2025.106003.
    >> Share

  17. XI Y, He C, Fang X, Yin JC, et al
    Analysis of Discordance between Mismatch Repair and Microsatellite Instability Testing in Endometrial Cancer.
    Hum Pathol. 2025 Dec 8:106004. doi: 10.1016/j.humpath.2025.106004.
    >> Share

    October 2025
  18. SCHOOLMEESTER JK, Hodge JC, Swanson AA
    HMGA2 and RB1 profiling in uterine and broad ligament leiomyomas with adipocytic differentiation: An immunohistochemical and fluorescence in situ hybridization study of 14 conventional and variant lipoleiomyomas.
    Hum Pathol. 2025 Oct 12:105950. doi: 10.1016/j.humpath.2025.105950.
    >> Share

  19. HOHN AK, Hiller GGR, Wolf B, Forberger M, et al
    Assessment of Nectin4-expression in vulvar squamous cell carcinomas (VSCC): correlation with HPV-associated and HPV-independent molecular subtypes.
    Hum Pathol. 2025;164:105926.
    >> Share

    August 2025
  20. QIN L, Lin W, Huang S, Zheng W, et al
    High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 Mutations: Clinicopathologic characteristics and novel molecular events.
    Hum Pathol. 2025;164:105928.
    >> Share

    July 2025
  21. LEENEN S, Kooreman L, Bulten J, Esch EMGV, et al
    The occurrence and histopathological recognition of atypical endometriosis in patients with ovarian endometriosis - a retrospective cohort study.
    Hum Pathol. 2025 Jul 22:105875. doi: 10.1016/j.humpath.2025.105875.
    >> Share

    June 2025
  22. LEI T, Liu B, Wei Y, Shi Y, et al
    Female reproductive tract inflammatory myofibroblastic tumor (IMT): A comprehensive analysis of clinicopathological and genomic features in a case series, including the identification of SERPINE1-ALK fusion in the fallopian tube.
    Hum Pathol. 2025;160:105839.
    >> Share

  23. ZHONG F, Ren Z, Li W, Jones T, et al
    The sensitivity and specificity of Claudin18.2 and MUC6 in the differential diagnosis of endocervical gastric-type glandular lesions.
    Hum Pathol. 2025;160:105837.
    >> Share

    May 2025
  24. TEKIN B, Cheville JC, Milosevic D, McCarthy M, et al
    Assessment of trophoblast cell-surface antigen 2 (TROP2) and nectin-4 expression in choriocarcinoma.
    Hum Pathol. 2025;159:105815.
    >> Share

  25. ZHANG Y, Karimi SS, Requena DO, Khararjian A, et al
    Intestinal and liver involvement by endometrial stromal sarcoma: Expanding the differential diagnosis of mesenchymal tumors involving the GI tract.
    Hum Pathol. 2025;158:105784.
    >> Share

  26. MILLER CH, Vemuri A, Lengyel E, Lastra RR, et al
    Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score.
    Hum Pathol. 2025;159:105800.
    >> Share

    March 2025
  27. HE D, Jin L, Geng H, Cao L, et al
    Deep learning-based analysis of gross features for ovarian epithelial tumors classification: A tool to assist pathologists for frozen section sampling.
    Hum Pathol. 2025;157:105762.
    >> Share

  28. ZHANG Z, Shi H, Shao Y, Lu B, et al
    Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
    Hum Pathol. 2025;157:105769.
    >> Share

  29. ZHENG L, Tabet G, Guo CC, Rizvi YO, et al
    Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis.
    Hum Pathol. 2025;157:105767.
    >> Share

    January 2025
  30. NODA Y, Tokuyama Y, Sumita W, Kita M, et al
    Hepatocyte nuclear factor 4alpha as a sensitive marker for uterine endocervical adenocarcinomas and their precursors.
    Hum Pathol. 2025;155:105714.
    >> Share

  31. SCHOOLMEESTER JK, Gupta S, Boland JM, Al Kateb H, et al
    Ovarian Epithelioid Tumor with FUS::CREM Fusion and Multilineage Protein Expression: Report of a Case in the EWSR1/FUS-CREB Tumor Spectrum.
    Hum Pathol. 2025 Jan 8:105712. doi: 10.1016/j.humpath.2024.105712.
    >> Share

    December 2024
  32. KHAEFPANAH D, Zare S, Hasteh F, Shi WJ, et al
    Characterization of gastric/gastrointestinal-like immunophenotypes in endometrial endometrioid adenocarcinomas, including endometrioid adenocarcinomas with mucinous differentiation.
    Hum Pathol. 2024;154:105707.
    >> Share

  33. ZHANG Y, Ju B, Cheng R, Ding T, et al
    PD-L1 expression and immune infiltration across molecular subtypes of endometrial cancer: An integrative-analysis of molecular classification and immune subtypes.
    Hum Pathol. 2024;154:105704.
    >> Share

    November 2024
  34. ACOSTA AM, Fletcher CDM, Sholl LM, van Leenders GJ, et al
    Fluorescence in-situ hybridization assessment of spindle cell-rich testicular sex cord stromal tumors demonstrates multiple chromosomal gains across histologic subtypes.
    Hum Pathol. 2024;153:105652.
    >> Share

    October 2024
  35. BROUARD M, Mobarki M, Peoc'h M, Karpathiou G, et al
    SALL4 expression is very rare in endometrial endometrioid and serous carcinoma.
    Hum Pathol. 2024 Oct 24:105675. doi: 10.1016/j.humpath.2024.105675.
    >> Share

  36. TABET GC, Zheng L, Hosseini H, Ward J, et al
    Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.
    Hum Pathol. 2024 Oct 24:105673. doi: 10.1016/j.humpath.2024.105673.
    >> Share

  37. DASHTI NK, Swanson AA, Bentz J, Xing D, et al
    DICER1-sarcomas of GYN tract: Expanding on an emerging entity.
    Hum Pathol. 2024;152:105636.
    >> Share

    September 2024
  38. KEENEY M, Keeney GL, Cheville JC, Gupta S, et al
    VHL-mutated papillary cystadenoma of the mesosalpinx with omental tumor deposits and immunophenotypic overlap with mesothelioma.
    Hum Pathol. 2024;151:105617.
    >> Share

    August 2024
  39. NAKAJIMA J, Yano M, Zaitsu S, Kamada K, et al
    Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma.
    Hum Pathol. 2024 Aug 16:105649. doi: 10.1016/j.humpath.2024.105649.
    >> Share

    July 2024
  40. ZELISSE HS, Dijk F, van Gent MDJM, Hooijer GKJ, et al
    Improving histotyping precision: the impact of immunohistochemical algorithms on epithelial ovarian cancer classification.
    Hum Pathol. 2024 Jul 29:105631. doi: 10.1016/j.humpath.2024.105631.
    >> Share

    May 2024
  41. NAVARRO SANCHEZ JM, Finkelman BS, Tyburski H, Turner BM, et al
    Performance of HER2 DAKO HercepTest and Ventana 4B5 Immunohistochemical Assays on Detecting HER2 Gene-Amplification in Uterine Serous Carcinomas.
    Hum Pathol. 2024 May 11:S0046-8177(24)00086.
    >> Share

    April 2024
  42. NGO C, Cotteret S, Deneche I, Kfoury M, et al
    Uterine adenosarcoma: clinical significance of histological classification and SNP array analysis.
    Hum Pathol. 2024 Apr 28:S0046-8177(24)00083.
    >> Share

  43. GUPTA S, Schoolmeester JK, Cheville JC
    Expanding the Spectrum of Paratesticular Mullerian-Origin Tumors: Adenocarcinoma with Mixed Serous and Endometrioid Features and Clear Cell Carcinoma.
    Hum Pathol. 2024 Apr 27:S0046-8177(24)00060.
    >> Share

    August 2023
  44. SMITHGALL MC, Liu-Jarin X, Chen X, Singh K, et al
    Diagnostic utility of PRAME immunohistochemistry in PEComa family of tumors and morphologic mimics with emphasis on the gynecologic tract.
    Hum Pathol. 2023;138:12-17.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016